[go: up one dir, main page]

MA24608A1 - COMPOSITIONS CONTAINING AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALPHAT-GLUGOSIDASE INHIBITOR ANTI-HEPERGLYCEMIC AGENT. - Google Patents

COMPOSITIONS CONTAINING AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALPHAT-GLUGOSIDASE INHIBITOR ANTI-HEPERGLYCEMIC AGENT.

Info

Publication number
MA24608A1
MA24608A1 MA25172A MA25172A MA24608A1 MA 24608 A1 MA24608 A1 MA 24608A1 MA 25172 A MA25172 A MA 25172A MA 25172 A MA25172 A MA 25172A MA 24608 A1 MA24608 A1 MA 24608A1
Authority
MA
Morocco
Prior art keywords
insulin
heperglycemic
glugosidase
alphat
agent
Prior art date
Application number
MA25172A
Other languages
French (fr)
Inventor
Stephen Alistair Smith
Robin Edwin Buckingham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA24608A1 publication Critical patent/MA24608A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
MA25172A 1997-07-18 1998-07-16 COMPOSITIONS CONTAINING AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALPHAT-GLUGOSIDASE INHIBITOR ANTI-HEPERGLYCEMIC AGENT. MA24608A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
MA24608A1 true MA24608A1 (en) 1999-04-01

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25172A MA24608A1 (en) 1997-07-18 1998-07-16 COMPOSITIONS CONTAINING AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALPHAT-GLUGOSIDASE INHIBITOR ANTI-HEPERGLYCEMIC AGENT.

Country Status (27)

Country Link
EP (1) EP1001784A1 (en)
JP (1) JP2001510160A (en)
KR (1) KR20010021952A (en)
CN (1) CN1263467A (en)
AP (1) AP2000001735A0 (en)
AR (2) AR016350A1 (en)
AU (1) AU8449098A (en)
BG (1) BG104062A (en)
BR (1) BR9810292A (en)
CA (1) CA2297133A1 (en)
CO (1) CO4940489A1 (en)
DZ (1) DZ2563A1 (en)
EA (1) EA200000140A1 (en)
GB (1) GB9715298D0 (en)
HU (1) HUP0003626A3 (en)
ID (1) ID23804A (en)
IL (1) IL133907A0 (en)
MA (1) MA24608A1 (en)
NO (1) NO20000230D0 (en)
OA (1) OA11312A (en)
PE (1) PE99499A1 (en)
PL (1) PL338140A1 (en)
SK (1) SK612000A3 (en)
TR (1) TR200000133T2 (en)
UY (1) UY25101A1 (en)
WO (1) WO1999003478A1 (en)
ZA (1) ZA986364B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
WO2000078333A2 (en) 1999-06-21 2000-12-28 Eli Lilly And Company Synergetic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependant diabetes
DK1741446T3 (en) * 2000-01-21 2008-06-02 Novartis Pharma Ag Combinations containing dipeptidyl peptidase IV inhibitors and antidiabetic agents
JP4917712B2 (en) * 2000-02-24 2012-04-18 武田薬品工業株式会社 Concomitant medication
AU2001234114A1 (en) * 2000-02-24 2001-09-03 Takeda Chemical Industries Ltd. Drugs containing combined active ingredients
BRPI0206432A2 (en) 2001-01-12 2016-10-25 Sun Pharmaceutical Ind Ltd methods for administering two or more active therapeutic agents and for treating diabetes mellitus or symptoms associated with diabetes mellitus in a human and spaced drug release system
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICINES FOR TREATING DIABETES
US7700128B2 (en) 2003-10-31 2010-04-20 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
PE99499A1 (en) 1999-12-18
ID23804A (en) 2000-05-11
HUP0003626A3 (en) 2001-12-28
CO4940489A1 (en) 2000-07-24
SK612000A3 (en) 2000-07-11
UY25101A1 (en) 2000-12-29
WO1999003478A1 (en) 1999-01-28
JP2001510160A (en) 2001-07-31
AR019724A2 (en) 2002-03-13
NO20000230L (en) 2000-01-17
PL338140A1 (en) 2000-09-25
BR9810292A (en) 2000-09-19
BG104062A (en) 2000-11-30
AP2000001735A0 (en) 2000-01-16
CA2297133A1 (en) 1999-01-28
OA11312A (en) 2003-10-24
AU8449098A (en) 1999-02-10
ZA986364B (en) 2000-01-17
EP1001784A1 (en) 2000-05-24
NO20000230D0 (en) 2000-01-17
GB9715298D0 (en) 1997-09-24
EA200000140A1 (en) 2000-06-26
HUP0003626A2 (en) 2001-05-28
KR20010021952A (en) 2001-03-15
IL133907A0 (en) 2001-04-30
CN1263467A (en) 2000-08-16
DZ2563A1 (en) 2003-02-15
TR200000133T2 (en) 2000-09-21
AR016350A1 (en) 2001-07-04

Similar Documents

Publication Publication Date Title
EP0578507A3 (en) Cleaning composition based on an amino redox compound.
LU91138I2 (en) Insulin glulisine and its pharmaceutically acceptable derivatives.
DE69812985D1 (en) BUSINESS CARD AGENT AND APPLICATION
BR9611184B8 (en) COMPOUND AND COMPOSITION.
NO2006016I1 (en) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
ATE277050T1 (en) TRIZYCLIC VASOPRESSIN AGONISTS
NO995891D0 (en) LH-RH peptide analogues, uses and pharmaceutical compositions containing them
DZ2562A1 (en) Composition containing an insulin sensitizer, an insulin secretagogue and an anti-hyperglycemic biguanide.
TR199801541A3 (en) Anti-Parasite function of N, N-Diethyl-m-Toluamide (DEET)
PT1047300E (en) MIXTURES FUNGICIDES BASED ON AMIDA AND AZOIS COMPOUNDS
ID21413A (en) TURUNAN-TURUNAN 1,3,8, -TRIAZA-SPIRO (4,5) DEKAN-4-ON
DK0975312T3 (en) Compositions containing an antifungal agent and a phospholipid
TR199800988A3 (en) 5 'Deoxy-Citidine derivatives.
MA24608A1 (en) COMPOSITIONS CONTAINING AN INSULIN SENSITIZER, AN INSULIN SECRETAGOG AND AN ALPHAT-GLUGOSIDASE INHIBITOR ANTI-HEPERGLYCEMIC AGENT.
EP0605983A3 (en) Insulin analogues.
DZ2937A1 (en) New compositions of insulin sensitizers.
IT1302243B1 (en) SUMMARY OF 1,1,1,3,3-PENTAFLUOROPROPANO.
FR2692479B1 (en) Polymeric dental composition containing a metallic compound.
IT1303793B1 (en) "PHARMACEUTICAL COMPOSITION INCLUDING A DONOR ORGANIC COMPOUND OF NITRIC OXIDE (NO)"
AR019331A2 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN INSULIN SENSITIZER AND AN INSULIN SECRETAGOG.
CH684920GA3 (en) Timepiece.
NO964684D0 (en) 2- (Aminomethyl) -3,4,7,9-tetrahydro-2H-pyrano- [2,3-eÅ indol-8-ones and derivatives
EP0639018A3 (en) Time sensitive messaging.
IT1295369B1 (en) COMPOSITION BASED ON TIAMFENICOLO AND DICLOFENAC
ID24047A (en) TURUNAN 5-SUBSTITUTUS-3-OKSAZIAZOLIL 1,6-NAFTIRIDIN-2 1H-ON